Clinical trial
Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults…
NCT00190879 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00190879 |
|---|---|
| Title | Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder |
| Official title | Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder, Comorbid Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine hydrochloride, placebo |
| Enrollment | 440 |
| Start date | Jun 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 8, 2007 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: